Andrew J. Fromkin Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 10 hours ago
Andrew J. Fromkin has an estimated net worth of at least $13.7 million*, as of yesterday. They own 131,400 shares of IMVT stock. They have sold 264,550 shares of IMVT stock since 2021, for an estimated $8.6 million.
Andrew J. Fromkin $IMVT SEC Form 4 Insider Trading
Andrew J. Fromkin has filed a total of 10 insider trades in $IMVT since 2021. Their most recent trade was a sale of 11,483 shares, made on May 28, 2026. Their largest trade was a sale of 210,468 shares, made on May 28, 2026. We estimate that they now own 131,400 shares of $IMVT, worth an estimated $5.1 million.
Insider Trading at $IMVT
There have been a total of 243 insider trades reported at $IMVT since 2021, with 35.5 million shares purchased and 1.7 million shares sold. The most active insider traders in $IMVT stock have been Peter Salzmann, William L. Macias, and Eva Renee Barnett. The most recent trade was a sale of 1,930 shares reported by Melanie Gloria (Chief Operating Officer), made on Jul 08, 2026.
History of Insider Stock Trades by Andrew J. Fromkin
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
IMVT
|
Sale | 11,483 | May 28, 2026 | May 29, 2026, 4:04 p.m. |
|
IMVT
|
Sale | 210,468 | May 28, 2026 | May 29, 2026, 4:04 p.m. |
|
IMVT
|
Sale | 19,351 | Dec 01, 2025 | Dec. 3, 2025, 7:14 p.m. |
|
IMVT
|
Sale | 2,898 | Dec 01, 2025 | Dec. 3, 2025, 7:14 p.m. |
|
IMVT
|
Sale | 1,384 | Mar 07, 2025 | March 11, 2025, 4:18 p.m. |
|
IMVT
|
Sale | 6,616 | Mar 07, 2025 | March 11, 2025, 4:18 p.m. |
|
IMVT
|
Sale | 3,941 | Dec 01, 2023 | Dec. 5, 2023, 5:30 p.m. |
|
IMVT
|
Sale | 3,636 | Dec 01, 2023 | Dec. 5, 2023, 5:30 p.m. |
|
IMVT
|
Sale | 4,773 | Dec 01, 2023 | Dec. 5, 2023, 5:30 p.m. |
|
IMVT
|
Purchase | 5,500 | Aug 10, 2021 | Aug. 10, 2021, 8 p.m. |
$IMVT Executives and Stock Owners with Insider Trades
-
Peter Salzmann, Chief Executive Officer
-
William L. Macias, Chief Medical Officer
-
Eva Renee Barnett, Chief Financial Officer
-
Mark S. Levine, Chief Legal Officer
-
Jay S Stout, Chief Technology Officer
-
Julia G. Butchko, Chief Development Officer
-
Julia G. Butchko, Chief Dev. & Tech. Officer
-
Michael Geffner, Chief Medical Officer
-
Melanie Gloria, Chief Operating Officer
-
Tuyl Christopher Van, Chief Legal Officer
-
Eric Venker, Chief Executive Officer
-
Tiago Girao, Chief Financial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.